##chargement des packages----
library(questionr)
library(tidyverse)
## ── Attaching core tidyverse packages ──────────────────────── tidyverse 2.0.0 ──
## ✔ dplyr 1.1.1 ✔ readr 2.1.4
## ✔ forcats 1.0.0 ✔ stringr 1.5.0
## ✔ ggplot2 3.4.2 ✔ tibble 3.2.1
## ✔ lubridate 1.9.2 ✔ tidyr 1.3.0
## ✔ purrr 1.0.1
## ── Conflicts ────────────────────────────────────────── tidyverse_conflicts() ──
## ✖ dplyr::filter() masks stats::filter()
## ✖ dplyr::lag() masks stats::lag()
## ℹ Use the conflicted package (<http://conflicted.r-lib.org/>) to force all conflicts to become errors
library(tableone)
library(labelled)
library(gtsummary)
library(GGally)
## Registered S3 method overwritten by 'GGally':
## method from
## +.gg ggplot2
library(readxl)
library(effects)
## Le chargement a nécessité le package : carData
## lattice theme set by effectsTheme()
## See ?effectsTheme for details.
library(survival)
library(survminer)
## Le chargement a nécessité le package : ggpubr
##
## Attachement du package : 'survminer'
##
## L'objet suivant est masqué depuis 'package:survival':
##
## myeloma
library(ggplot2)
library(dplyr)
library(knitr)
library(cowplot)
##
## Attachement du package : 'cowplot'
##
## L'objet suivant est masqué depuis 'package:ggpubr':
##
## get_legend
##
## L'objet suivant est masqué depuis 'package:lubridate':
##
## stamp
library(readxl)
ct_classe <- read_excel("C:/datar/ct_classe.xlsx")
##recodage des variables et bases de données le cas échéant----
var_label(ct_classe$tox_dig) <- "Toxicité digestive"
var_label(ct_classe$tox_muq) <- "Toxicité muqueuse"
var_label(ct_classe$tox_cut) <- "Toxicité cutanée"
var_label(ct_classe$tox_cardio) <- "Toxicité cardiovasculaire"
var_label(ct_classe$tox_oph) <- "Toxicité ophtalmique"
var_label(ct_classe$tox_plum) <- "Toxicité pulmonaire"
var_label(ct_classe$tox_gale) <- "Toxicité générale"
var_label(ct_classe$tox_hemato) <- "Toxicité hématologique"
var_label(ct_classe$tox_musq_os) <- "Toxicité musqulosqueletique"
var_label(ct_classe$tox_rein) <- "Toxicité rénale"
var_label(ct_classe$tox_foie) <- "Toxicité hépatique"
var_label(ct_classe$tox_neuro) <- "Toxicité neuroologique"
var_label(ct_classe$tox_psy) <- "Toxicité psychiatrique"
var_label(ct_classe$tox_bio) <- "Toxicité biologique"
##renommer des variables pour présentation dans les tableaux de résultat
tbl_summary(
ct_classe, include = c("tox_dig", "tox_muq", "tox_cut",
"tox_cardio", "tox_oph", "tox_plum",
"tox_gale","tox_hemato" ,"tox_musq_os", "tox_rein",
"tox_foie", "tox_neuro", "tox_psy", "tox_bio"),
statistic = all_continuous() ~ "{median} [{min} - {max}]",
digits=all_categorical()~ c(0,1)
)
| Characteristic |
N = 65 |
| Toxicité digestive |
|
| acidité gastrique |
1 (2.4%) |
| constipation |
10 (23.8%) |
| diarrhée |
12 (28.6%) |
| diarrhée brûlure anus nausée |
1 (2.4%) |
| diarrhée douleur gorge |
1 (2.4%) |
| diarrhée gaz |
1 (2.4%) |
| diarrhée nausée |
1 (2.4%) |
| douleur au ventre |
2 (4.8%) |
| douleur gastrique |
2 (4.8%) |
| douleurs gastriques |
1 (2.4%) |
| gastrite diarrhée constipation nausée |
1 (2.4%) |
| nausée |
2 (4.8%) |
| nausée constipation |
1 (2.4%) |
| nausée vomissement |
1 (2.4%) |
| nausée vomissement diarrhée |
1 (2.4%) |
| pesanteur gastrique |
1 (2.4%) |
| pyrosis |
1 (2.4%) |
| selles impérieuses |
1 (2.4%) |
| vomissement |
1 (2.4%) |
| Unknown |
23 |
| Toxicité muqueuse |
|
| Aphtes |
3 (17.6%) |
| Gencives fragilisée |
1 (5.9%) |
| Gingivite |
1 (5.9%) |
| Hyposialies nocturnes |
1 (5.9%) |
| Langue rouge |
1 (5.9%) |
| Mucite |
2 (11.8%) |
| Mucites, sécheresse |
1 (5.9%) |
| Sécheresse |
1 (5.9%) |
| Sècheresse |
1 (5.9%) |
| Sécheresse buccale |
2 (11.8%) |
| Sècheresse buccale |
1 (5.9%) |
| Sécheresse vaginale |
1 (5.9%) |
| Stomatite |
1 (5.9%) |
| Unknown |
48 |
| Toxicité cutanée |
|
| Abcès frottement culotte |
1 (3.3%) |
| Acné juvénile |
1 (3.3%) |
| Boutons |
1 (3.3%) |
| Boutons, crevasse |
1 (3.3%) |
| Boutons, prurit |
1 (3.3%) |
| Boutons, rash, sécheresse |
1 (3.3%) |
| Boutons, sécheresse |
1 (3.3%) |
| Cheveux cassants |
1 (3.3%) |
| Croûtes cuir chevelu |
1 (3.3%) |
| Eruption cutanée granuleuse, crevasses |
1 (3.3%) |
| Eruptions acnéiformes |
1 (3.3%) |
| Escarre |
1 (3.3%) |
| Ongles fragiles |
1 (3.3%) |
| Prurit et couperoses |
1 (3.3%) |
| Prurit, pellicules |
1 (3.3%) |
| Prurit, rougeurs |
1 (3.3%) |
| Rash |
3 (10.0%) |
| Rash, sécheresse |
1 (3.3%) |
| Rash, sécheresse, ongle incarné |
1 (3.3%) |
| Sécheresse |
5 (16.7%) |
| Sécheresse buccale, nez bouché |
1 (3.3%) |
| Sécheresse, éruption |
1 (3.3%) |
| Sécheresse, fissure, brûlure |
1 (3.3%) |
| Sécheresse, rash |
1 (3.3%) |
| Unknown |
35 |
| Toxicité cardiovasculaire |
|
| Augmentation volume jambes et cuisses |
1 (6.7%) |
| Hypertension |
3 (20.0%) |
| Jambes lourdes |
2 (13.3%) |
| Oedème |
1 (6.7%) |
| Œdème |
4 (26.7%) |
| Oedèmes MI et visage, tachycardie |
1 (6.7%) |
| Palpitations |
1 (6.7%) |
| Thrombose |
1 (6.7%) |
| Thrombose veineuse |
1 (6.7%) |
| Unknown |
50 |
| Toxicité ophtalmique |
|
| Carré noir champ de vision |
1 (16.7%) |
| Difficulté à l'accomodation |
1 (16.7%) |
| Diploplie, vision floue, perte des couleurs |
1 (16.7%) |
| Halo oculaire |
1 (16.7%) |
| Sécheresse oculaire |
2 (33.3%) |
| Unknown |
59 |
| Toxicité pulmonaire |
|
| Dyspnée |
3 (20.0%) |
| Laryngite |
1 (6.7%) |
| Mucus |
1 (6.7%) |
| Mucus jaunes |
1 (6.7%) |
| Oppression thoracique |
1 (6.7%) |
| Toux |
5 (33.3%) |
| Toux, dyspnée |
1 (6.7%) |
| Toux, mucus épais |
1 (6.7%) |
| Toux, oppression thoracique |
1 (6.7%) |
| Unknown |
50 |
| Toxicité générale |
|
| Asthénie |
5 (20.0%) |
| Asthénie, perte d'appétit |
4 (16.0%) |
| Asthénie, perte de poids, agueusie |
1 (4.0%) |
| Asthénie, perte de poids, dysgueusie |
1 (4.0%) |
| Dysgueusie |
1 (4.0%) |
| Fatigue, perte d'appétit |
1 (4.0%) |
| Kyste sébacé dorsal, maux de gorge |
1 (4.0%) |
| Perte d'appétit |
5 (20.0%) |
| Perte de poids |
5 (20.0%) |
| Perte de poids, anosmie, dysgueusie |
1 (4.0%) |
| Unknown |
40 |
| Toxicité hématologique |
|
| Anémie |
1 (16.7%) |
| Epistaxis |
3 (50.0%) |
| Hématome |
1 (16.7%) |
| Thrombopénie |
1 (16.7%) |
| Unknown |
59 |
| Toxicité musqulosqueletique |
|
| Crampes |
2 (9.1%) |
| Cruralgie, épanchement de la cheville |
1 (4.5%) |
| Douleur |
1 (4.5%) |
| Douleur au genou |
1 (4.5%) |
| Douleur aux mollets |
1 (4.5%) |
| Douleur dorsale |
1 (4.5%) |
| Douleur dos, cervicales |
1 (4.5%) |
| Douleurs |
5 (22.7%) |
| Douleurs articulaires |
1 (4.5%) |
| Faiblesse à la jambe |
1 (4.5%) |
| Faiblesse musculaire |
1 (4.5%) |
| Fatigue musculaire, douleur au pied |
1 (4.5%) |
| Fracture du fémur |
1 (4.5%) |
| Fracture du poignet |
1 (4.5%) |
| Fracture, douleur |
1 (4.5%) |
| Mysthénie |
1 (4.5%) |
| tendinite |
1 (4.5%) |
| Unknown |
43 |
| Toxicité rénale |
|
| Infections urinaires |
1 (25.0%) |
| insuffisance renale aigue fonctionnelle |
1 (25.0%) |
| Suspiscion d'infection urinaire |
1 (25.0%) |
| Urines foncées |
1 (25.0%) |
| Unknown |
61 |
| Toxicité hépatique |
|
| Ascite |
1 (33.3%) |
| Douleur au foie |
2 (66.7%) |
| Unknown |
62 |
| Toxicité neuroologique |
|
| Céphalée, vertige |
1 (9.1%) |
| céphalées |
1 (9.1%) |
| Confusion |
1 (9.1%) |
| Paresthésie |
2 (18.2%) |
| Syndrome de la queue de cheval, tremblements |
1 (9.1%) |
| Tremblement, paresthésie |
1 (9.1%) |
| Trouble du sommeil |
2 (18.2%) |
| Vertige |
1 (9.1%) |
| Vertige, céphalée |
1 (9.1%) |
| Unknown |
54 |
| Toxicité psychiatrique |
|
| Anxiété |
2 (33.3%) |
| Dépression |
1 (16.7%) |
| Trouble de l'humeur |
2 (33.3%) |
| Trouble du sommeil |
1 (16.7%) |
| Unknown |
59 |
| Toxicité biologique |
|
| Augmentation cholestérol, glycémie 0,6 |
1 (12.5%) |
| Augmentation CPK |
2 (25.0%) |
| Augmentation des CPK |
2 (25.0%) |
| Augmentation PAL et CPK |
1 (12.5%) |
| hypokaliémie |
1 (12.5%) |
| Hypokaliémie |
1 (12.5%) |
| Unknown |
57 |
##
tbl_summary(
ct_classe, include = c("tox_dig", "tox_cut", "tox_muq",
"tox_cardio", "tox_oph", "tox_plum",
"tox_gale","tox_hemato" ,"tox_musq_os", "tox_rein",
"tox_foie", "tox_neuro", "tox_psy", "tox_bio"),
statistic = all_continuous() ~ "{median} [{min} - {max}]",
by="medt",
digits=all_categorical()~ c(0,1)
)
| Characteristic |
Afatinib, N = 5 |
Alectinib, N = 5 |
Brigatinib, N = 6 |
Cabozantinib, N = 2 |
Crizotinib, N = 2 |
Dabrafénib/Trametinib, N = 1 |
Evérolimus, N = 4 |
Lenvatinib, N = 1 |
Lorlatinib, N = 5 |
Mobocertinib, N = 2 |
Osimertinib, N = 26 |
Osimertinib/Crizotinib, N = 1 |
Sotorasib, N = 5 |
| Toxicité digestive |
|
|
|
|
|
|
|
|
|
|
|
|
|
| acidité gastrique |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (25.0%) |
| constipation |
0 (0.0%) |
3 (100.0%) |
0 (NA%) |
1 (100.0%) |
2 (100.0%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
2 (11.1%) |
0 (0.0%) |
0 (0.0%) |
| diarrhée |
3 (60.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
7 (38.9%) |
0 (0.0%) |
1 (25.0%) |
| diarrhée brûlure anus nausée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| diarrhée douleur gorge |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
| diarrhée gaz |
1 (20.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| diarrhée nausée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| douleur au ventre |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
2 (11.1%) |
0 (0.0%) |
0 (0.0%) |
| douleur gastrique |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
2 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| douleurs gastriques |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
| gastrite diarrhée constipation nausée |
1 (20.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| nausée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
1 (25.0%) |
| nausée constipation |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (25.0%) |
| nausée vomissement |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
| nausée vomissement diarrhée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
| pesanteur gastrique |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
| pyrosis |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (5.6%) |
0 (0.0%) |
0 (0.0%) |
| selles impérieuses |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| vomissement |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
| Unknown |
0 |
2 |
6 |
1 |
0 |
0 |
2 |
0 |
3 |
0 |
8 |
0 |
1 |
| Toxicité cutanée |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Abcès frottement culotte |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Acné juvénile |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Boutons |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Boutons, crevasse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Boutons, prurit |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Boutons, rash, sécheresse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Boutons, sécheresse |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Cheveux cassants |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Croûtes cuir chevelu |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Eruption cutanée granuleuse, crevasses |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Eruptions acnéiformes |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Escarre |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
| Ongles fragiles |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Prurit et couperoses |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Prurit, pellicules |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
| Prurit, rougeurs |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Rash |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
1 (50.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Rash, sécheresse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Rash, sécheresse, ongle incarné |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Sécheresse |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
3 (18.8%) |
0 (NA%) |
0 (0.0%) |
| Sécheresse buccale, nez bouché |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
| Sécheresse, éruption |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Sécheresse, fissure, brûlure |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (6.2%) |
0 (NA%) |
0 (0.0%) |
| Sécheresse, rash |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Unknown |
1 |
3 |
6 |
2 |
2 |
0 |
3 |
1 |
4 |
0 |
10 |
1 |
2 |
| Toxicité muqueuse |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aphtes |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
3 (37.5%) |
0 (NA%) |
0 (NA%) |
| Gencives fragilisée |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
| Gingivite |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Hyposialies nocturnes |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
| Langue rouge |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Mucite |
2 (50.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Mucites, sécheresse |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Sécheresse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
| Sècheresse |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
| Sécheresse buccale |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Sècheresse buccale |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
1 (12.5%) |
0 (NA%) |
0 (NA%) |
| Sécheresse vaginale |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Stomatite |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Unknown |
1 |
4 |
6 |
1 |
2 |
0 |
4 |
1 |
4 |
1 |
18 |
1 |
5 |
| Toxicité cardiovasculaire |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Augmentation volume jambes et cuisses |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Hypertension |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
2 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Jambes lourdes |
0 (NA%) |
1 (33.3%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Oedème |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Œdème |
0 (NA%) |
2 (66.7%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Oedèmes MI et visage, tachycardie |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
| Palpitations |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Thrombose |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
| Thrombose veineuse |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Unknown |
5 |
2 |
5 |
0 |
1 |
0 |
2 |
0 |
3 |
2 |
24 |
1 |
5 |
| Toxicité ophtalmique |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Carré noir champ de vision |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
| Difficulté à l'accomodation |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Diploplie, vision floue, perte des couleurs |
1 (50.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Halo oculaire |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
| Sécheresse oculaire |
1 (50.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Unknown |
3 |
4 |
6 |
2 |
2 |
1 |
4 |
1 |
5 |
1 |
24 |
1 |
5 |
| Toxicité pulmonaire |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dyspnée |
0 (NA%) |
2 (66.7%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
0 (0.0%) |
| Laryngite |
0 (NA%) |
1 (33.3%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Mucus |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Mucus jaunes |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
0 (0.0%) |
| Oppression thoracique |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
0 (0.0%) |
| Toux |
0 (NA%) |
0 (0.0%) |
2 (66.7%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
1 (50.0%) |
| Toux, dyspnée |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (20.0%) |
0 (NA%) |
0 (0.0%) |
| Toux, mucus épais |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (50.0%) |
| Toux, oppression thoracique |
0 (NA%) |
0 (0.0%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Unknown |
5 |
2 |
3 |
2 |
2 |
0 |
4 |
1 |
4 |
2 |
21 |
1 |
3 |
| Toxicité générale |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Asthénie |
0 (0.0%) |
1 (100.0%) |
2 (100.0%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Asthénie, perte d'appétit |
1 (33.3%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
2 (100.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
| Asthénie, perte de poids, agueusie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (11.1%) |
0 (NA%) |
0 (0.0%) |
| Asthénie, perte de poids, dysgueusie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
| Dysgueusie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Fatigue, perte d'appétit |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (11.1%) |
0 (NA%) |
0 (0.0%) |
| Kyste sébacé dorsal, maux de gorge |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (11.1%) |
0 (NA%) |
0 (0.0%) |
| Perte d'appétit |
1 (33.3%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
2 (22.2%) |
0 (NA%) |
1 (33.3%) |
| Perte de poids |
1 (33.3%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
3 (33.3%) |
0 (NA%) |
0 (0.0%) |
| Perte de poids, anosmie, dysgueusie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (11.1%) |
0 (NA%) |
0 (0.0%) |
| Unknown |
2 |
4 |
4 |
1 |
1 |
1 |
1 |
1 |
5 |
0 |
17 |
1 |
2 |
| Toxicité hématologique |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anémie |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
| Epistaxis |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
2 (50.0%) |
0 (NA%) |
0 (0.0%) |
| Hématome |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (25.0%) |
0 (NA%) |
0 (0.0%) |
| Thrombopénie |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (25.0%) |
0 (NA%) |
0 (0.0%) |
| Unknown |
4 |
5 |
6 |
2 |
2 |
1 |
4 |
1 |
5 |
2 |
22 |
1 |
4 |
| Toxicité musqulosqueletique |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Crampes |
0 (0.0%) |
0 (0.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
| Cruralgie, épanchement de la cheville |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
| Douleur |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
| Douleur au genou |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Douleur aux mollets |
0 (0.0%) |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Douleur dorsale |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Douleur dos, cervicales |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
| Douleurs |
0 (0.0%) |
1 (25.0%) |
1 (50.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
2 (28.6%) |
0 (NA%) |
1 (33.3%) |
| Douleurs articulaires |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Faiblesse à la jambe |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Faiblesse musculaire |
0 (0.0%) |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Fatigue musculaire, douleur au pied |
0 (0.0%) |
1 (25.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Fracture du fémur |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
| Fracture du poignet |
1 (50.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Fracture, douleur |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
| Mysthénie |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| tendinite |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
1 (14.3%) |
0 (NA%) |
0 (0.0%) |
| Unknown |
3 |
1 |
4 |
2 |
2 |
1 |
4 |
0 |
2 |
2 |
19 |
1 |
2 |
| Toxicité rénale |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Infections urinaires |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
| insuffisance renale aigue fonctionnelle |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
| Suspiscion d'infection urinaire |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Urines foncées |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Unknown |
5 |
5 |
6 |
2 |
2 |
1 |
3 |
0 |
5 |
2 |
25 |
1 |
4 |
| Toxicité hépatique |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ascite |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
| Douleur au foie |
0 (NA%) |
0 (NA%) |
2 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
| Unknown |
5 |
5 |
4 |
2 |
2 |
1 |
4 |
1 |
4 |
2 |
26 |
1 |
5 |
| Toxicité neuroologique |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Céphalée, vertige |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| céphalées |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
| Confusion |
1 (50.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Paresthésie |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
1 (33.3%) |
| Syndrome de la queue de cheval, tremblements |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
| Tremblement, paresthésie |
1 (50.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Trouble du sommeil |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (0.0%) |
| Vertige |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
| Vertige, céphalée |
0 (0.0%) |
0 (NA%) |
1 (33.3%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
| Unknown |
3 |
5 |
3 |
2 |
2 |
1 |
4 |
1 |
5 |
2 |
23 |
1 |
2 |
| Toxicité psychiatrique |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anxiété |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
| Dépression |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
| Trouble de l'humeur |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
2 (100.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
| Trouble du sommeil |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
| Unknown |
5 |
5 |
6 |
2 |
1 |
1 |
3 |
1 |
3 |
1 |
26 |
1 |
4 |
| Toxicité biologique |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Augmentation cholestérol, glycémie 0,6 |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Augmentation CPK |
0 (NA%) |
2 (66.7%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Augmentation des CPK |
0 (NA%) |
0 (0.0%) |
2 (100.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Augmentation PAL et CPK |
0 (NA%) |
1 (33.3%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| hypokaliémie |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (NA%) |
| Hypokaliémie |
0 (NA%) |
0 (0.0%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
0 (NA%) |
1 (100.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (0.0%) |
0 (NA%) |
0 (NA%) |
| Unknown |
5 |
2 |
4 |
2 |
2 |
1 |
3 |
1 |
4 |
2 |
25 |
1 |
5 |
##